Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight-loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker.
Lilly's price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.
Customers who buy a month's supply of 2.5 mg vials will pay $299, a $50 reduction from the previous price of $349. The 5 mg vials will cost $399, down from $499.
Four higher dosages – 7.5 mg, 10 mg, 12.5 mg and 15 mg – will sell for $449. The previous price for higher-dosage vials was $499.
In a statement, Lilly USA President Ilya Yuffa said far too many people who need obesity medication "still face cost and coverage barriers."
